Dapagliflozin in Heart Failure
Not Applicable
- Conditions
- Health Condition 1: I501- Left ventricular failure, unspecified
- Registration Number
- CTRI/2022/11/047725
- Lead Sponsor
- Sanjay Kumar R
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients willing singned informed consent
2.Patients with documented diagnosis of HFpEF and HFmrEF with medical history of symptoms and signs of Heart Failure
3.Patients with LVEF 40-60% or evidence of structural Heat disease
Exclusion Criteria
1.Patients who are not willing to sign informed consent.
2.Patients with LVEF <40%
3.Patients with eGFR <25ml/min/1.73m3
4.Patients who are intolerance to Dapagliflozin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method